Related references
Note: Only part of the references are listed.Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
Yumeng Mao et al.
CLINICAL CANCER RESEARCH (2014)
KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells
Yusuke Nakadate et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in 51Cr-release and CD107a assays
Mariana M. Mata et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD2 Antibody
Nikolai Siebert et al.
PLOS ONE (2014)
Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells
A. Moller-Larsen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Cancer immunotherapy - revisited
W. Joost Lesterhuis et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Effects of cryopreservation on CD4+CD25+T cells of HIV-1 infected individuals
Anna C. Seale et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2008)
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2
Stefania Varchetta et al.
CANCER RESEARCH (2007)
Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic disease
Andrew G. Robinson et al.
CLINICAL BREAST CANCER (2006)
Maximizing the retention of antigen specific lymphocyte function after cryopreservation
ML Disis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population
I Jedema et al.
BLOOD (2004)
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2
R Gennari et al.
CLINICAL CANCER RESEARCH (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Effects of cryopreservation on lymphocyte immunophenotype and function
A Costantini et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity
E Derby et al.
IMMUNOLOGY LETTERS (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry
K Godoy-Ramirez et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
Share Paper
